[Therapy of chronic heart failure with positive inotropic drugs].
D002118:Calcium / Q000378:metabolism; D002395:Catecholamines / Q000627:therapeutic use; D002908:Chronic Disease; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000201:enzymology; D010210:Papillary Muscles / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011955:Receptors, Drug / Q000187:drug effects; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
D002395:Catecholamines; D004071:Digitalis Glycosides; D010726:Phosphodiesterase Inhibitors; D011955:Receptors, Drug; C027082:digitalis receptor; D000254:Sodium-Potassium-Exchanging ATPase; D002118:Calcium
Therapie der chronischen Herzinsuffizienz mit positiv inotropen Pharmaka.